To use all functions of this page, please activate cookies in your browser.
My watch list
my.chemeurope.com
my.chemeurope.com
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
SatraplatinSatraplatin is a platinum compound that is currently under investigation as one treatment of patients with advanced prostate cancer who have failed previous chemotherapy. As an investigation drug, it has not yet received U.S. Food and Drug Administration (FDA) approval and is not available in retail pharmacies. Product highlightThe drug is taken by mouth. It is made available in the United States jointly by Spectrum Pharmaceuticals and GPCbiotech under the name Spera. The drug has also been used in the treatment of lung and ovarian cancers. The mode of action is that the compound binds to the DNA of cancer cells rendering them incapable of dividing. [1] References
|
| This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Satraplatin". A list of authors is available in Wikipedia. |
Last viewed
- Great Lakes Delivers Solutions and Real Cost Savings with Lines of Polymer Additives Blends
- Isotopes_of_gadolinium
- Vistant Enters Into Exclusive Global Agreement With Sigma-Aldrich to Provide Vistant Automation Technology
- Sulfur Analysis in Fuels: SPECTRO XEPOS Achieves Detection Limit of 1 mg/kg
- Anti-obesity_drug
